Critical Care

official impact factor 4.60

This article is part of the supplement: Severe community-acquired pneumonia update: mortality, mechanisms and medical intervention

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

Pierre-Francois Laterre

Critical Care 2008, 12(Suppl 6):S4 doi:10.1186/cc7027

Accesses  

  • Last 30 days: 44 accesses
  • Last year: 425 accesses
  • All time: 2706 accesses

Cited by

BioMed Central: 2 citations

Review   Free

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia

Mirjam Christ-Crain, Steven M Opal Critical Care 2010, 14:203 (8 February 2010)

Introduction   Free Highly Accessed

Severe community acquired pneumonia update: mortality, mechanisms and medical intervention

Pierre-Francois Laterre Critical Care 2008, 12(Suppl 6):S1 (26 November 2008)